Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Acute Nausea and Vomitting Treatment
1.3.3 Delayed Nausea and Vomitting Treatment
1.3.4 Anticipatory Nausea and Vomitting Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Perspective (2018-2029)
2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Growth Trends by Region
2.2.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Region (2018-2024)
2.2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2024-2029)
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Dynamics
2.3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Trends
2.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
2.3.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
2.3.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Chemotheraphy-induced Nausea and Vomitting Treatment by Players
3.1.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2018-2024)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio
3.4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2022
3.5 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment Head office and Area Served
3.6 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Product and Application
3.7 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Type
4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Type (2018-2024)
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2024-2029)
5 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Application
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Application (2018-2024)
5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
6.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
6.2.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024)
6.2.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029)
6.2.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
6.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
6.3.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024)
6.3.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029)
6.3.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
6.4 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
6.4.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
6.4.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
7.2.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024)
7.2.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029)
7.2.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
7.3.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024)
7.3.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029)
7.3.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
7.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
7.4.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
7.4.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
8.2 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
8.2.1 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024)
8.2.2 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029)
8.2.3 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
8.3 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
8.3.1 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024)
8.3.2 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029)
8.3.3 China Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
9.2 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
9.2.1 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024)
9.2.2 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029)
9.2.3 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
9.3 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
9.3.1 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024)
9.3.2 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029)
9.3.3 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
9.4 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region
9.4.1 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024)
9.4.3 Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Helsinn
11.2.1 Helsinn Company Details
11.2.2 Helsinn Business Overview
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.2.4 Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.2.5 Helsinn Recent Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Details
11.3.2 Heron Therapeutics Business Overview
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.3.4 Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.3.5 Heron Therapeutics Recent Developments
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.4.4 Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.4.5 Merck & Co Recent Developments
11.5 Tesaro
11.5.1 Tesaro Company Details
11.5.2 Tesaro Business Overview
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.5.4 Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.5.5 Tesaro Recent Developments
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Details
11.6.2 Acacia Pharma Business Overview
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.6.4 Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.6.5 Acacia Pharma Recent Developments
11.7 Aphios
11.7.1 Aphios Company Details
11.7.2 Aphios Business Overview
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.7.4 Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.7.5 Aphios Recent Developments
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Details
11.8.2 Barr Laboratories Business Overview
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.8.4 Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.8.5 Barr Laboratories Recent Developments
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.9.5 Baxter Healthcare Recent Developments
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.10.4 Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.10.5 Eisai Recent Developments
11.11 Especificos Stendhal
11.11.1 Especificos Stendhal Company Details
11.11.2 Especificos Stendhal Business Overview
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.11.4 Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.11.5 Especificos Stendhal Recent Developments
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Details
11.12.2 F.Hoffmann La Roche Business Overview
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.12.4 F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.12.5 F.Hoffmann La Roche Recent Developments
11.13 Mundipharma
11.13.1 Mundipharma Company Details
11.13.2 Mundipharma Business Overview
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.13.4 Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.13.5 Mundipharma Recent Developments
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.14.5 Mylan Pharmaceuticals Recent Developments
11.15 OPKO Health
11.15.1 OPKO Health Company Details
11.15.2 OPKO Health Business Overview
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.15.4 OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.15.5 OPKO Health Recent Developments
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Details
11.16.2 Orchid Healthcare Business Overview
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.16.4 Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.16.5 Orchid Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of 5-HT3 Inhibitors
Table 3. Key Players of NK1 Inhibitors
Table 4. Key Players of Others
Table 5. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2018-2024)
Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2024-2029)
Table 11. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
Table 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Players (2018-2024)
Table 17. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2022)
Table 18. Global Chemotheraphy-induced Nausea and Vomitting Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Headquarters and Area Served
Table 21. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Product and Application
Table 22. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Application (2018-2024)
Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Share by Application (2024-2029)
Table 32. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Chemotheraphy-induced Nausea and Vomitting Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 67. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. Helsinn Company Details
Table 70. Helsinn Business Overview
Table 71. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 72. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 73. Helsinn Recent Developments
Table 74. Heron Therapeutics Company Details
Table 75. Heron Therapeutics Business Overview
Table 76. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 77. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 78. Heron Therapeutics Recent Developments
Table 79. Merck & Co Company Details
Table 80. Merck & Co Business Overview
Table 81. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 82. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 83. Merck & Co Recent Developments
Table 84. Tesaro Company Details
Table 85. Tesaro Business Overview
Table 86. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 87. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 88. Tesaro Recent Developments
Table 89. Acacia Pharma Company Details
Table 90. Acacia Pharma Business Overview
Table 91. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 92. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 93. Acacia Pharma Recent Developments
Table 94. Aphios Company Details
Table 95. Aphios Business Overview
Table 96. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 97. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 98. Aphios Recent Developments
Table 99. Barr Laboratories Company Details
Table 100. Barr Laboratories Business Overview
Table 101. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 102. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 103. Barr Laboratories Recent Developments
Table 104. Baxter Healthcare Company Details
Table 105. Baxter Healthcare Business Overview
Table 106. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 107. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 108. Baxter Healthcare Recent Developments
Table 109. Eisai Company Details
Table 110. Eisai Business Overview
Table 111. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 112. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 113. Eisai Recent Developments
Table 114. Especificos Stendhal Company Details
Table 115. Especificos Stendhal Business Overview
Table 116. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 117. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 118. Especificos Stendhal Recent Developments
Table 119. F.Hoffmann La Roche Company Details
Table 120. F.Hoffmann La Roche Business Overview
Table 121. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 122. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 123. F.Hoffmann La Roche Recent Developments
Table 124. Mundipharma Company Details
Table 125. Mundipharma Business Overview
Table 126. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 127. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 128. Mundipharma Recent Developments
Table 129. Mylan Pharmaceuticals Company Details
Table 130. Mylan Pharmaceuticals Business Overview
Table 131. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 132. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 133. Mylan Pharmaceuticals Recent Developments
Table 134. OPKO Health Company Details
Table 135. OPKO Health Business Overview
Table 136. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 137. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 138. OPKO Health Recent Developments
Table 139. Orchid Healthcare Company Details
Table 140. Orchid Healthcare Business Overview
Table 141. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 142. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 143. Orchid Healthcare Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2022 VS 2029
Figure 3. 5-HT3 Inhibitors Features
Figure 4. NK1 Inhibitors Features
Figure 5. Others Features
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2022 VS 2029
Figure 8. Acute Nausea and Vomitting Treatment Case Studies
Figure 9. Delayed Nausea and Vomitting Treatment Case Studies
Figure 10. Anticipatory Nausea and Vomitting Treatment Case Studies
Figure 11. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2022
Figure 16. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2022
Figure 18. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
Figure 20. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
Figure 21. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 22. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
Figure 26. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
Figure 27. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 28. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
Figure 36. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
Figure 37. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
Figure 39. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
Figure 40. Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2018-2029)
Figure 41. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 51. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 58. Helsinn Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 59. Heron Therapeutics Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 60. Merck & Co Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 61. Tesaro Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 62. Acacia Pharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 63. Aphios Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 64. Barr Laboratories Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 65. Baxter Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 66. Eisai Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 67. Especificos Stendhal Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 68. F.Hoffmann La Roche Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 69. Mundipharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 70. Mylan Pharmaceuticals Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 71. OPKO Health Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 72. Orchid Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed